MAKO Surgical: Burden of Proof Still on Management
Most Popular - MAKO Surgical’s (MAKO) first quarter results did little to inspire our confidence in this battered and bruised story, but for those that truly believe in … Continue Reading
Read NowQuick Picks
The ThermoDox Data Release: Utilizing Options to Minimize Risk
Quick Picks - Shares of Celsion Corp. (NASDAQ:CLSN) have climbed 103% since PropThink last wrote on the ThermoDox developer in November, which is due to release pivotal Phase … Continue Reading
Read NowUnofficially, Complete Genomics, BGI, Illumina Chronicle At an End
Quick Picks - It looks like BGI-Shenzhen may be close to unequivocally beating out fellow bidder Illumina (NASDAQ:ILMN) in securing a buyout of Complete Genomics (NASDAQ:GNOM). Last Friday, … Continue Reading
Read NowA Number of Factors Contributing to Dendreon’s New Year Rally
Quick Picks - Biotech investors will be well-aware of the Dendreon (NASDAQ:DNDN) story – its rise to glory from 2009 to 2011 and subsequent fall from grace over … Continue Reading
Read NowTivozanib and AVEO: Valuation Suggests Upside Ahead of FDA Decision
Long Ideas - It seems that shares of AVEO Oncology (NASDAQ:AVEO) may have finally found their bottom. The oncology drug-developer bounced off of support at $6 (a triple … Continue Reading
Read NowJazz Citizen Petition Rejected, Removing One More Barrier to Entry for a Generic Xyrem
Quick Picks - A Citizen Petition that Jazz Pharmaceuticals (JAZZ) filed with the FDA in July of 2012 has been rejected, says the company, negating one more barrier … Continue Reading
Read NowSQNM Jumps as Investors Gain Confidence with New Patent
Quick Picks - Shares of Sequenom (SQNM) climbed 6% on Friday morning as investors took confidence in the announcement of a new patent issuance covering Sequenom’s methods for … Continue Reading
Read Now